Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -309,851 | -312,222 | -251,497 | -78,178 | -306,735 |
| Depreciation Amortization | 224,807 | 124,939 | 111,931 | 7,983 | 13,694 |
| Income taxes - deferred | -205 | N/A | N/A | N/A | -11,424 |
| Accounts receivable | 9,091 | 7,232 | 4,182 | 6,292 | -17,829 |
| Accounts payable and accrued liabilities | 1,405 | -2,222 | 3,390 | 6,644 | 206 |
| Other Working Capital | -40,578 | -48,945 | -31,677 | -25,348 | -58,957 |
| Other Operating Activity | -90,727 | 55,810 | 33,726 | 6,925 | 121,872 |
| Operating Cash Flow | $-206,058 | $-175,408 | $-129,945 | $-75,682 | $-259,173 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 130,192 | 70,337 | 48,059 | -30,257 | 13,549 |
| PPE Investments | -6,188 | -4,571 | -5,358 | -3,879 | -8,843 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -102 |
| Investing Cash Flow | $124,004 | $65,766 | $42,701 | $-34,136 | $4,604 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -490 | -490 | -490 | -338 | -1,842 |
| Common Stock Issued | 7,703 | 7,703 | 6,891 | 6,891 | 204,519 |
| Other Financing Activity | -50,200 | 0 | 0 | 0 | -93,786 |
| Financing Cash Flow | $-42,987 | $7,213 | $6,401 | $6,553 | $108,891 |
| Beginning Cash Position | 182,633 | 182,633 | 182,633 | 182,633 | 328,311 |
| End Cash Position | 57,592 | 80,204 | 101,790 | 79,368 | 182,633 |
| Net Cash Flow | $-125,041 | $-102,429 | $-80,843 | $-103,265 | $-145,678 |
| Free Cash Flow | |||||
| Operating Cash Flow | -206,058 | -175,408 | -129,945 | -75,682 | -259,173 |
| Capital Expenditure | -6,188 | -4,571 | -5,358 | -3,879 | -8,843 |
| Free Cash Flow | -212,246 | -179,979 | -135,303 | -79,561 | -268,016 |